Related Experiment Video
Updated: Aug 9, 2026
10:24
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.2K
Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop
S Robert Levine1, Martin G Myers2, Ryan Barunas3
1Mary Tyler Moore Vision Initiative, Greenwich, CT, USA.
Translational Vision Science & Technology
|November 28, 2023
Summary
The Mary Tyler Moore Vision Initiative workshop focused on advancing diabetic retinal disease (DRD) research. Key goals include updating DRD staging, creating a biorepository, and developing new diagnostic and therapeutic strategies.
Area of Science:
- Ophthalmology
- Diabetic Retinopathy Research
- Neurovascular Health
Background:
- Diabetic Retinal Disease (DRD) impacts a significant patient population.
- Current diagnostic and therapeutic approaches for DRD require advancement.
- Restoring retinal neurovascular unit integrity is crucial for vision preservation.
Purpose of the Study:
- To accelerate progress in establishing clinical and research endpoints for DRD.
- To foster the development of novel therapeutics for DRD.
- To address the full spectrum of DRD pathology.
Main Methods:
- Convened a workshop with over 90 stakeholders, including patients, clinicians, scientists, and industry representatives.
- Discussed unmet needs in diagnostic and therapeutic strategies for DRD.
- Focused on advancing Phase I plans of the Mary Tyler Moore Vision Initiative.
Main Results:
- Emphasized the need for updated DRD staging and severity scales.
- Highlighted the importance of establishing a human ocular biorepository.
- Stressed the necessity of clinical endpoint and biomarker development and validation.
Conclusions:
- The workshop identified critical areas for improving DRD management and research.
- Collaborative efforts are essential for developing effective interventions for DRD.
- The Mary Tyler Moore Vision Initiative's Phase I plans are pivotal for future DRD progress.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...